QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rafarma Pharmaceuticals, Inc. (RAFA) Continues To Build Drug Pipeline 0 comments
    May 16, 2013 1:17 PM

    Rafarma Pharmaceuticals is one of Russia's newest and most promising pharmaceutical companies. A company whose development and growth is being actively encouraged by the government, in a move to lessen Russian dependence upon western pharmaceutical companies for widely used pharmaceuticals, Rafarma is currently specializing in the production of generic antibiotics, but has a growing pipeline of other drugs, including proprietary products already approved.

    The company expects significant near-term results with its line of current and researched pharmaceuticals, including the following group of antibiotics.

    • Benzalconium Fluoride - Open randomized study of the efficacy and safety of the drug "benzalkonium fluoride, topical solution 1 %" in patients with purulent-infected wounds.

    • Benzomet - Open randomized study of the efficacy and safety of the drug "benzomet, vaginal suppositories" in patients with urogenital trichomoniasis.

    • Benzolete - Open randomized study of the efficacy and safety of "benzolete, lozenges for resorption - 1 mg" in patients with inflammatory diseases of the mucous membranes of the oral cavity and pharynx.

    • Benzoteks - Open randomized study comparative study of the efficacy and safety of the drug "benzoteks, vaginal suppositories with benzalkonium FLUORIDE - 18.9 mg" in patients with bacterial vaginosis.

    Below is a list of various Rafarma products, in order of expected sales (NYSEARCA:USD) by 2014. Rafarma also deals with many drugs for contracted production.

    • Pasco ($5,910,186)

    • Amoxicillin+clav-k ($5,700,175)

    • Azithromycin ($4,782,939)

    • Clopidogrel ($4,088,210)

    • Betahistine ($3,795,417)

    • Glibenclamide+Metformin ($3,463,513)

    • Metoprolol ($2,911,183)

    • Metformin ($2,865,075)

    • Bisoprolol ($2,418,957)

    • Levofloxacin ($2,338,084)

    • Glycine ($2,274,287)

    • Vancomycin ($1,467,387)

    • Quetiapine ($1,354,435)

    • Cefotaxime ($1,193,041)

    • Clarithromycin ($1,015,775)

    • Ciprofloxacin ($839,219)

    • Ibuprofen ($749,831)

    • Glimepiride ($719,375)

    • Norfloxacin ($710,766)

    • Glibenclamide ($653,162)

    • Doxycycline ($548,019)

    • Risperidone ($486,959)

    • Cefuroxime ($399,884)

    • Ofloxacin ($362,786)

    • Amoxicillin + sulbactam ($196,700)

    • Capreomycin ($192,502)

    • Lomefloksatsin ($59,309)

    For more information, visit rafarma.us

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.